The document summarizes a presentation on using big data to enable patient centricity in clinical research. It discusses how all players in healthcare are focusing on the patient and how pharma companies can overcome barriers to access patients. It also outlines different ways companies can understand and engage patients, including through interviews, online/mobile solutions, and financial support. The presentation notes that big data can provide a better understanding of healthcare consumers and ultimately enhance patient treatment across clinical trials and a drug's lifecycle. However, challenges around organizational culture, data governance, and technology adoption must be overcome to fully realize patient centricity.
MHEALTH
1) mHealth has the potential to improve healthcare delivery through increased efficiency, access to information, and ability to positively impact patient behavior and health outcomes.
2) However, mHealth faces many barriers to widespread adoption including resistance from entrenched healthcare providers and systems, lack of incentives for different stakeholders, and performance issues with many early mHealth applications.
3) For mHealth to succeed, applications must address important healthcare pain points, have a validated product, and a detailed adoption plan that engages key decision makers and addresses barriers within the complex healthcare system. Widespread adoption may take many years.
The Population Health Management Market 2015Lifelog Health
Population health management is a problem term because it can mean something different to each person who hears it. However, I believe that the words capture the overall spirit and energy of healthcare reform in a unique way. Providers are thinking big when it comes to a patient’s engagement, responsibility, and preventative care, and they’re leveraging technology to do it. I discuss an overall picture of PHM, present some useful technology, and tell a few PHM stories herein.
The Agile Approach to Patient Journey Marketing Carl Olsen
Patient journeys are one of the hottest topics in health care marketing and with good reason. They can achieve excellent results by directing engagement tactics to where an individual consumer is on the decision-making continuum for elective health care services. By segmenting consumers along the journey, health systems The Agile Approach to Patient Journey Marketing can attain increased utilization, enhanced patient satisfaction and heightened loyalty.
Within the first three months, 479 visitors responded to the one ad UC Health ran on Facebook. Twenty-five percent of visitors signed up for a seminar, took the quiz or downloaded documents from the microsite; and those 120 prospects provided a name, email address and other information that could be used in future consumer engagement initiatives. Seminar registrations increased 4 percent, and the conversion rate for surgery nearly doubled by month three.
Ashfield Head of Clinical – Europe, Nagore Fernandez, presented at eyeforpharma 2017, sharing learnings from Ashfield’s 15 years of experience delivering patient support services. The presentation covers how to design, deliver and measure a truly differentiated patient support programme, as well as practical do’s and don’ts for success.
#e4pbarca #unitepharma, adherence, behaviour change, eyeforpharma 2017, patient enrolment, patient outcomes, patient support programmes, psp,
Adding value and patient-centric services and innovation in pharmaplanetkatara
Umamiflow/Katara, VAST Health and the Antwerp Management School (AMS) collaborated on 3 scientific questions: challenges for innovation implementation, a good innovation scan and the service model as alternative for pharmaceutical companies. The analysis was fed by both pharmaceutical companies and patient organizations. Are they ready to go from cure to care?
Jennifer Clawson is an Associate Director at The Boston Consulting Group and coordinates their global value-based healthcare program. She played a key role in establishing ICHOM, an organization focused on standardizing healthcare outcome measurements. ICHOM has developed 21 standard sets covering common conditions that define important outcomes and costs. Leading healthcare organizations around the world are adopting ICHOM standards to measure and improve value. Studies show that focusing on outcomes through standardized measurement can simultaneously improve health outcomes and reduce costs.
MHEALTH
1) mHealth has the potential to improve healthcare delivery through increased efficiency, access to information, and ability to positively impact patient behavior and health outcomes.
2) However, mHealth faces many barriers to widespread adoption including resistance from entrenched healthcare providers and systems, lack of incentives for different stakeholders, and performance issues with many early mHealth applications.
3) For mHealth to succeed, applications must address important healthcare pain points, have a validated product, and a detailed adoption plan that engages key decision makers and addresses barriers within the complex healthcare system. Widespread adoption may take many years.
The Population Health Management Market 2015Lifelog Health
Population health management is a problem term because it can mean something different to each person who hears it. However, I believe that the words capture the overall spirit and energy of healthcare reform in a unique way. Providers are thinking big when it comes to a patient’s engagement, responsibility, and preventative care, and they’re leveraging technology to do it. I discuss an overall picture of PHM, present some useful technology, and tell a few PHM stories herein.
The Agile Approach to Patient Journey Marketing Carl Olsen
Patient journeys are one of the hottest topics in health care marketing and with good reason. They can achieve excellent results by directing engagement tactics to where an individual consumer is on the decision-making continuum for elective health care services. By segmenting consumers along the journey, health systems The Agile Approach to Patient Journey Marketing can attain increased utilization, enhanced patient satisfaction and heightened loyalty.
Within the first three months, 479 visitors responded to the one ad UC Health ran on Facebook. Twenty-five percent of visitors signed up for a seminar, took the quiz or downloaded documents from the microsite; and those 120 prospects provided a name, email address and other information that could be used in future consumer engagement initiatives. Seminar registrations increased 4 percent, and the conversion rate for surgery nearly doubled by month three.
Ashfield Head of Clinical – Europe, Nagore Fernandez, presented at eyeforpharma 2017, sharing learnings from Ashfield’s 15 years of experience delivering patient support services. The presentation covers how to design, deliver and measure a truly differentiated patient support programme, as well as practical do’s and don’ts for success.
#e4pbarca #unitepharma, adherence, behaviour change, eyeforpharma 2017, patient enrolment, patient outcomes, patient support programmes, psp,
Adding value and patient-centric services and innovation in pharmaplanetkatara
Umamiflow/Katara, VAST Health and the Antwerp Management School (AMS) collaborated on 3 scientific questions: challenges for innovation implementation, a good innovation scan and the service model as alternative for pharmaceutical companies. The analysis was fed by both pharmaceutical companies and patient organizations. Are they ready to go from cure to care?
Jennifer Clawson is an Associate Director at The Boston Consulting Group and coordinates their global value-based healthcare program. She played a key role in establishing ICHOM, an organization focused on standardizing healthcare outcome measurements. ICHOM has developed 21 standard sets covering common conditions that define important outcomes and costs. Leading healthcare organizations around the world are adopting ICHOM standards to measure and improve value. Studies show that focusing on outcomes through standardized measurement can simultaneously improve health outcomes and reduce costs.
The document discusses barriers to implementing value-based healthcare (VBHC) in Latin America and potential solutions. It identifies that the current healthcare system has misaligned incentives that prioritize volume over quality and outcomes. Key barriers to VBHC include lack of agreed outcome measures, data infrastructure to support it, and cross-stakeholder collaboration. The document proposes that VBHC requires measuring outcomes and costs, aligning payments to value, using data to drive continuous quality improvement, and gaining support across organizations.
How pharma and healthcare brands can improve their customer experienceJack Morton Worldwide
The SVP and Managing Director of Jack’s Chicago office, Matt Pensinger, presented at Lions Health 2015 with Katie Bang from Eli Lilly and Company about improving the customer experience for patients:
There is growing recognition amongst healthcare brands that understanding the full patient journey is essential for success in today’s healthcare environment. The sheer extent of this both physical and emotional journey, from awareness through to treatment and adherence, opens the patient to many potential experience gaps between their expectations and reality that can lead to frustration, disillusionment and even dropping the prescribed treatment.
So, healthcare companies must understand this journey if they are to improve the customer experience – and offer necessary patient support that extends far beyond a given medication. Being truly effective requires that the entire organisation (from science through to sales) understands the patient journey in order to meet patient needs and effectively engage the many stakeholders that are becoming increasingly important to a therapy’s success.
This is a significant undertaking and healthcare brands and their marketing agencies need to think differently about how they engage with patients and support communications for all the other stakeholders. This talk will examine the experience journey and what it means for the way we market.
This document discusses 5 elements of a successful patient engagement strategy:
1. Define your organization's vision for patient engagement.
2. Create a culture of engagement within the practice.
3. Employ the right technology and services like patient portals.
4. Empower patients to become collaborators in their care.
5. Continuously evaluate progress and be ready to adapt the strategy.
True patient engagement involves patients managing their own health, a practice culture that prioritizes engagement, and collaboration between patients and providers.
The Beryl Institute 2013 State of the Patient Experience Benchmarking StudyEngagingPatients
This document summarizes the key findings of a survey of over 1,000 US hospitals regarding their efforts to improve the patient experience. It finds that while patient experience remains a top priority, hospitals feel somewhat less positive about their progress than two years ago. Most hospitals now have a formal definition and structure for patient experience. Leadership support and HCAHPS scores are the top factors driving patient experience work. Hospitals continue focusing on communication, noise reduction, and discharge processes to improve patient experience.
Generating Quality Data through Collaborative Research with an ACOTodd Berner MD
This document summarizes a presentation about generating quality data through collaborative research with an ACO. The number of public and private ACOs is growing rapidly, with over 250 CMS MSSP ACOs covering 4 million Medicare beneficiaries. The goal of the collaborative research is to disseminate valued information on effectiveness and costs of care to payers and policymakers. Real-world evidence studies can provide insights beyond randomized controlled trials by observing patient outcomes across delivery system models. Measuring quality requires considering multiple stakeholder perspectives to identify metrics that drive improvement and have utility.
How to design effective and efficient real world trials TB Evidence 2014 10.2...Todd Berner MD
This document discusses strategies for designing effective and efficient real-world clinical trials. It covers topics such as using real-world evidence to inform clinical trial design, the differences between efficacy and effectiveness, challenges in defining quality metrics, and strategies for improving performance within healthcare systems. The document provides information on pragmatic clinical trials and how real-world evidence could reduce costs compared to traditional clinical trials.
The document discusses adopting a customer-focused mindset when designing medical affairs programs to create more engaging communications in the "Age of Personalization". It notes that attention spans are shrinking while information exposure is greater. Healthcare professionals feel pressure from inefficient systems and data overload. Effective communications need to gain a deeper understanding of audiences, create personalized communication plans, and develop personalized content. This involves understanding barriers/drivers, tailoring content to individuals based on traits and dynamic data, and adapting an educational system based on individual progress.
Exploring The Interests Of Physicians And Sales Reps On The Exhibit Hall Floorprimed.com
The document discusses strategies for pharmaceutical companies to maximize their exposure and engagement with physicians at medical conventions. It provides insights into physician preferences and behaviors regarding continuing medical education. Specifically, it outlines four success stories of companies that 1) paired exhibit space with a sponsorship, 2) implemented a passport program, 3) used a CRM tool to qualify leads, and 4) sponsored a product education theater. It also provides recommendations for convention selection criteria focusing on efficiencies, formats, outreach capabilities, metrics, and floor plan innovation.
SCOPE 2015: Online Communities & Mobile Communication Impact on Recruitment ...Imperial CRS
In a joint presentation with Dennis Upah of Remedy Health Media, Melynda Geurts of DAC Patient Recruitment Services discusses the impact of online communities and mobile communication on patient recruitment and retention for clinical trials.
Highlights from ExL Pharma's 2nd Pharmaceutical Managed MarketsExL Pharma
This document summarizes highlights from ExLPharma's 2nd Pharmaceutical Managed Markets Insight and Marketing conference held in February 2010 in Philadelphia. It discusses concerns from healthcare providers around quality of care, patient access to drugs, and costs. It also outlines strategies pharmaceutical companies can take to address these concerns, including keeping providers informed, convincing health plan medical directors, and streamlining charity care guidelines. The document emphasizes that with the right strategies, patients, insurers, hospitals, and pharmaceutical companies can all benefit through improved patient access and care, reduced costs, and increased sales.
Customer Advisory Groups: Another Way to Listen to the Marketplacejasonbritt
This document discusses the use of Customer Advisory Groups (CAGs) by UK HealthCare to gather feedback from key stakeholders. It provides examples of different CAGs established, including a Physician Marketing Advisory Group, Referring Physician Roundtable, Employee Marketing Advisory Group, and Main Campus Employee Advisory Group. The document outlines the objectives, membership, meeting schedules, and agendas of these CAGs. It also summarizes the key accomplishments and insights gained from regularly meeting with these advisory groups to improve marketing, customer experience, and operations at UK HealthCare.
Creating a standard of care for patient and family engagementChristine Winters
Nationally-recognized governance expert Beth Daley Ullem addresses the state of patient engagement in heathcare and provides a vision for establishing a minimum standard of care for patient engagement programs.
3rd Annual Customer Centric Medical Information AgendaTracey Zdravkovic
This document provides information about the 3rd Annual Customer Centric Medical Information conference taking place July 25-26, 2016 in Boston, MA. The conference will feature presentations and panels from medical information directors and executives from various pharmaceutical companies on topics such as transforming medical information content, analyzing clinical trial data, implementing new communication channels, and leveraging metrics. It also includes the schedule, list of speakers, and descriptions of presentation topics each day.
Sills MR. Overview of the SAFTINet Program. Presented to the Emergency Department Research Committee, Department of Pediatrics, University of Colorado School of Medicine. 6 January 2015.
Closing the Loop: Strategies to Extend Care in the EDEngagingPatients
This HIMSS15 presentation discusses the challenges faced in hospital emergency departments and offers insights for implementing a process to follow up with discharged ED patients to enhance outcomes and satisfaction,while optimizing utilization and reducing risk.
This document discusses patient engagement and outlines strategies that health systems have used to increase engagement. It begins with an overview of a framework for patient and family engagement in health and healthcare. It then provides examples from various health systems of strategies they have implemented to increase engagement and discusses the results, such as improved outcomes and cost savings. Some of the key strategies discussed include shared decision making, care coordination, chronic disease management, and targeting interventions based on patient needs and activation levels. The document emphasizes that patient engagement is associated with better health outcomes, care experiences, and lower costs. It concludes that building a truly patient-centered healthcare system can improve quality in a way that benefits both patients and costs.
1) The document discusses how to capture patient-reported outcomes (PROs) and patient experiences to demonstrate value from the patient's perspective when securing access to treatments.
2) It notes that traditional clinical measures cannot capture how patients feel or function, so patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are needed.
3) The document argues that capturing the patient voice through PROMs/PREMs and involving patient groups can help define patient-relevant outcomes and the full value of treatment, including quality of life benefits, which are increasingly important to health technology assessments and payers.
Provider-payer Collaboration - New Secret for Value-based Success is Out NowInsights10
Transformations in care delivery models have propelled providers and payers to foster collaborations that will not only impact the quality of the care but also enhance their financial stability. These collaborations are majorly value-driven that partly contribute to social determinants of health and overall enhance patient health. To get a report in detail, contact us at - info@insights10.com
The document discusses barriers to implementing value-based healthcare (VBHC) in Latin America and potential solutions. It identifies that the current healthcare system has misaligned incentives that prioritize volume over quality and outcomes. Key barriers to VBHC include lack of agreed outcome measures, data infrastructure to support it, and cross-stakeholder collaboration. The document proposes that VBHC requires measuring outcomes and costs, aligning payments to value, using data to drive continuous quality improvement, and gaining support across organizations.
How pharma and healthcare brands can improve their customer experienceJack Morton Worldwide
The SVP and Managing Director of Jack’s Chicago office, Matt Pensinger, presented at Lions Health 2015 with Katie Bang from Eli Lilly and Company about improving the customer experience for patients:
There is growing recognition amongst healthcare brands that understanding the full patient journey is essential for success in today’s healthcare environment. The sheer extent of this both physical and emotional journey, from awareness through to treatment and adherence, opens the patient to many potential experience gaps between their expectations and reality that can lead to frustration, disillusionment and even dropping the prescribed treatment.
So, healthcare companies must understand this journey if they are to improve the customer experience – and offer necessary patient support that extends far beyond a given medication. Being truly effective requires that the entire organisation (from science through to sales) understands the patient journey in order to meet patient needs and effectively engage the many stakeholders that are becoming increasingly important to a therapy’s success.
This is a significant undertaking and healthcare brands and their marketing agencies need to think differently about how they engage with patients and support communications for all the other stakeholders. This talk will examine the experience journey and what it means for the way we market.
This document discusses 5 elements of a successful patient engagement strategy:
1. Define your organization's vision for patient engagement.
2. Create a culture of engagement within the practice.
3. Employ the right technology and services like patient portals.
4. Empower patients to become collaborators in their care.
5. Continuously evaluate progress and be ready to adapt the strategy.
True patient engagement involves patients managing their own health, a practice culture that prioritizes engagement, and collaboration between patients and providers.
The Beryl Institute 2013 State of the Patient Experience Benchmarking StudyEngagingPatients
This document summarizes the key findings of a survey of over 1,000 US hospitals regarding their efforts to improve the patient experience. It finds that while patient experience remains a top priority, hospitals feel somewhat less positive about their progress than two years ago. Most hospitals now have a formal definition and structure for patient experience. Leadership support and HCAHPS scores are the top factors driving patient experience work. Hospitals continue focusing on communication, noise reduction, and discharge processes to improve patient experience.
Generating Quality Data through Collaborative Research with an ACOTodd Berner MD
This document summarizes a presentation about generating quality data through collaborative research with an ACO. The number of public and private ACOs is growing rapidly, with over 250 CMS MSSP ACOs covering 4 million Medicare beneficiaries. The goal of the collaborative research is to disseminate valued information on effectiveness and costs of care to payers and policymakers. Real-world evidence studies can provide insights beyond randomized controlled trials by observing patient outcomes across delivery system models. Measuring quality requires considering multiple stakeholder perspectives to identify metrics that drive improvement and have utility.
How to design effective and efficient real world trials TB Evidence 2014 10.2...Todd Berner MD
This document discusses strategies for designing effective and efficient real-world clinical trials. It covers topics such as using real-world evidence to inform clinical trial design, the differences between efficacy and effectiveness, challenges in defining quality metrics, and strategies for improving performance within healthcare systems. The document provides information on pragmatic clinical trials and how real-world evidence could reduce costs compared to traditional clinical trials.
The document discusses adopting a customer-focused mindset when designing medical affairs programs to create more engaging communications in the "Age of Personalization". It notes that attention spans are shrinking while information exposure is greater. Healthcare professionals feel pressure from inefficient systems and data overload. Effective communications need to gain a deeper understanding of audiences, create personalized communication plans, and develop personalized content. This involves understanding barriers/drivers, tailoring content to individuals based on traits and dynamic data, and adapting an educational system based on individual progress.
Exploring The Interests Of Physicians And Sales Reps On The Exhibit Hall Floorprimed.com
The document discusses strategies for pharmaceutical companies to maximize their exposure and engagement with physicians at medical conventions. It provides insights into physician preferences and behaviors regarding continuing medical education. Specifically, it outlines four success stories of companies that 1) paired exhibit space with a sponsorship, 2) implemented a passport program, 3) used a CRM tool to qualify leads, and 4) sponsored a product education theater. It also provides recommendations for convention selection criteria focusing on efficiencies, formats, outreach capabilities, metrics, and floor plan innovation.
SCOPE 2015: Online Communities & Mobile Communication Impact on Recruitment ...Imperial CRS
In a joint presentation with Dennis Upah of Remedy Health Media, Melynda Geurts of DAC Patient Recruitment Services discusses the impact of online communities and mobile communication on patient recruitment and retention for clinical trials.
Highlights from ExL Pharma's 2nd Pharmaceutical Managed MarketsExL Pharma
This document summarizes highlights from ExLPharma's 2nd Pharmaceutical Managed Markets Insight and Marketing conference held in February 2010 in Philadelphia. It discusses concerns from healthcare providers around quality of care, patient access to drugs, and costs. It also outlines strategies pharmaceutical companies can take to address these concerns, including keeping providers informed, convincing health plan medical directors, and streamlining charity care guidelines. The document emphasizes that with the right strategies, patients, insurers, hospitals, and pharmaceutical companies can all benefit through improved patient access and care, reduced costs, and increased sales.
Customer Advisory Groups: Another Way to Listen to the Marketplacejasonbritt
This document discusses the use of Customer Advisory Groups (CAGs) by UK HealthCare to gather feedback from key stakeholders. It provides examples of different CAGs established, including a Physician Marketing Advisory Group, Referring Physician Roundtable, Employee Marketing Advisory Group, and Main Campus Employee Advisory Group. The document outlines the objectives, membership, meeting schedules, and agendas of these CAGs. It also summarizes the key accomplishments and insights gained from regularly meeting with these advisory groups to improve marketing, customer experience, and operations at UK HealthCare.
Creating a standard of care for patient and family engagementChristine Winters
Nationally-recognized governance expert Beth Daley Ullem addresses the state of patient engagement in heathcare and provides a vision for establishing a minimum standard of care for patient engagement programs.
3rd Annual Customer Centric Medical Information AgendaTracey Zdravkovic
This document provides information about the 3rd Annual Customer Centric Medical Information conference taking place July 25-26, 2016 in Boston, MA. The conference will feature presentations and panels from medical information directors and executives from various pharmaceutical companies on topics such as transforming medical information content, analyzing clinical trial data, implementing new communication channels, and leveraging metrics. It also includes the schedule, list of speakers, and descriptions of presentation topics each day.
Sills MR. Overview of the SAFTINet Program. Presented to the Emergency Department Research Committee, Department of Pediatrics, University of Colorado School of Medicine. 6 January 2015.
Closing the Loop: Strategies to Extend Care in the EDEngagingPatients
This HIMSS15 presentation discusses the challenges faced in hospital emergency departments and offers insights for implementing a process to follow up with discharged ED patients to enhance outcomes and satisfaction,while optimizing utilization and reducing risk.
This document discusses patient engagement and outlines strategies that health systems have used to increase engagement. It begins with an overview of a framework for patient and family engagement in health and healthcare. It then provides examples from various health systems of strategies they have implemented to increase engagement and discusses the results, such as improved outcomes and cost savings. Some of the key strategies discussed include shared decision making, care coordination, chronic disease management, and targeting interventions based on patient needs and activation levels. The document emphasizes that patient engagement is associated with better health outcomes, care experiences, and lower costs. It concludes that building a truly patient-centered healthcare system can improve quality in a way that benefits both patients and costs.
1) The document discusses how to capture patient-reported outcomes (PROs) and patient experiences to demonstrate value from the patient's perspective when securing access to treatments.
2) It notes that traditional clinical measures cannot capture how patients feel or function, so patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are needed.
3) The document argues that capturing the patient voice through PROMs/PREMs and involving patient groups can help define patient-relevant outcomes and the full value of treatment, including quality of life benefits, which are increasingly important to health technology assessments and payers.
Provider-payer Collaboration - New Secret for Value-based Success is Out NowInsights10
Transformations in care delivery models have propelled providers and payers to foster collaborations that will not only impact the quality of the care but also enhance their financial stability. These collaborations are majorly value-driven that partly contribute to social determinants of health and overall enhance patient health. To get a report in detail, contact us at - info@insights10.com
Patient engagement is evolving to include a composite of practices that impact patient behaviors and health. Contemporary models of patient engagement include the HIMSS 5 phases of patient engagement and the Regional Primary Care Coalition's 6 dimensions of patient engagement. Meaningful Use Phase 3 identifies key priorities around patient access to health records and secure messaging. Barriers to patient engagement include defining engagement and integrating diverse engagement tools and technologies.
Healthcare is undergoing a transformation. Consumers want to make informed choices and take control of their lives, and pharma companies must be ready to meet their needs. This means building a new healthcare ecosystem that places the patient at its center, with the “person” fully engaged in his or her own healthcare. But with this move to person-centric healthcare, payers and providers are no longer the main decision makers.
So what does this mean for today’s marketers?
In this exclusive Social On Us webinar we discuss:
- Where marketing is failing to address healthcare concerns
- How “big data” is a change-driver for a new healthcare ecosystem
- New opportunities for predictive and preventative medical intervention
- Impact of digital healthcare on patient privacy
Physicians are interested in adopting digital clinical tools if they:
1) Improve practice efficiency, increase patient safety, and enhance diagnostic ability.
2) Fit within existing systems and workflows.
3) Address concerns around data privacy, liability coverage, and reimbursement.
Physicians want to be involved in adoption decisions but also look to IT experts and practice leaders for guidance. Younger physicians see potential for tools to reduce burnout and strengthen patient relationships.
Year after year, technology has played a role in changing the way that health care is delivered. Now in 2014, as technology continues to advance, consumers are demanding more convenient and cost effective care through increased use of mHealth and Telehealth. The mHealth + Telehealth World 2014 is must attend event for health care executives interested in learning how to most efficiently utilize Telehealth programs and mHealth practices to improve patient outcomes by promoting interoperability, sustainability, provider interest, and consumer engagement. Hear case studies, understand the ROI, and discuss ways to address critical issues – including licensing and security issues – of digital health practices.
http://www.worldcongress.com/events/HL14028/
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...No Fixed Address Health
Learn about the shifting landscape within healthcare decision-making and how the traditional model has evolved into a more collaborative approach. Discover three drivers within the life science marketing landscape accelerating this shift and what this all means to Pharma Brand Marketers. What's at stake for a brand failing to address these shifts?
This document provides information about the "mHealth + Telehealth World" conference taking place from July 20-22, 2015 in Boston, MA. The conference will discuss implementing and expanding connected health programs, exploring examples of connected health success and outcomes, and engaging providers and consumers. Speakers will address topics like return on investment of connected health, reimbursement models, choosing technology solutions, bridging care across settings, increasing provider participation, evaluating mobile apps, consumer engagement strategies, and empowering consumers.
Situational analysis in health care industryAbhi Manu
The document discusses various techniques for conducting situational analysis in healthcare. It defines situational analysis as the systematic collection and study of past and present data to identify trends and conditions that can influence business performance and strategy choices. For healthcare, situational analysis describes and analyzes the health status and services in an area to assess how well services address needs. It also prioritizes problems to inform planning. Common techniques discussed include 5C analysis, PEST analysis, Porter's Five Forces, and SWOT analysis. A typical situational analysis identifies strengths, weaknesses, opportunities, and threats to help organizations maximize strengths and reduce weaknesses.
Situational analysis in health care industryAbhi Manu
The document discusses various techniques for conducting situational analysis in healthcare. It defines situational analysis as the systematic collection and study of past and present data to identify trends and conditions that can influence business performance and strategy choices. For healthcare, situational analysis describes and analyzes the health status and services in an area to assess how well services address needs. It also prioritizes problems to inform planning. Common techniques include 5C analysis, PEST analysis, Porter's Five Forces, and SWOT analysis. The summary provides an overview of how each technique is applied to understand strengths, weaknesses, opportunities and threats to better plan healthcare services.
Running Head: PHYSICIAN
PHYSICIAN 7
Health Care Provider: Physician
Marcia Harrison
Strayer University
Professor Hwangi Lu
July 28, 2019
Physician
Introduction
A healthcare system should be well organized and should consist of trained personnel who mainly work with a company or an organization. Physicians, nurses, doctors, pharmacists are some of the examples of health care providers. This is a system that provides professional services to patients that are in high need of treatment as inpatients who are treated generally as outpatients. I decided to select physicians as health care providers and also as medical practitioners since they are always in demand in the medical field, day after another. This is a professional medical practitioner or by simple terms, a doctor who has completed highly advanced training in providing a range of mostly non-surgical health care to patients. A physician should have adverse knowledge in a medical specialty. The main concern is to maintain, restore, and promote health via the study, treatment, and diagnosis of a disease of patients to ensure their wellbeing.
Direct Impact of a Physician
Most companies direct the efforts of their marketing towards physicians to the consumers who are their patients; the shots are put in the physicians through the sale of drugs and also by advertising in most of the medical journals. Most of the largest chunk is put in place towards the detailing of marketing expenditure through advertisement. Some direct adverse impacts towards physicians are the misleading claims, indications that are unapproved and also overstated clinical issues. It has led to patients heading to physicians on a matter regarding well preventive healthcare (Machanda, 2005) since most drug adverts have left patients having an excellent aid of discussions with their physicians regarding treatment through which only safe drugs are allowed.
Physicians and their patients have put into caution through dealing with advertisement of drugs as they use forums which are web-based for their advertisements as they have a literature of promotion on their background which makes them be excluded in the blacklist by companies and by the agency of the regulatory. The detailing through rifeness over the drugs life has been adopted as an explanation of better effectiveness and efficiency of physician firms and improvement of patient’s health. As an industry, it plays a vital role in the economy of the world and also promoting the welfare of the consumers who are the citizens of the nation towards the healthcare industry.
Strategy for a Physician
Data integrity is a critical strategy that physicians ought to adopt for the statistical review and pattern utilization as a technological step in the medical field, this will help in recoding the patients ...
Digital healthcare technologies are transforming healthcare delivery globally. Companies are developing technologies like mobile apps, big data analytics, and smart medical devices to improve patient monitoring and outcomes. These digital innovations extract insights from medical data to enhance healthcare provisioning, reduce costs, and support preventative care and remote patient monitoring. Emerging areas like bioinformatics and medical analytics utilize big data to provide actionable clinical insights.
Telehealth Failures & Secrets to Success Conference 2017 by VSee Speaker Series
Karyn DiGiorgio (University of California)
More info at: vsee.com/conference
Hello Bacsi thuộc tập đoàn Hello Health, được thành lập vào năm 2015 tại Việt Nam. Với mục tiêu trở thành đơn vị tiên phong cung cấp các thông tin về y tế được kiểm chứng bởi chuyên gia, Hello Health hiện đã có mặt tại 9 thị trường phát triển nhanh ở Châu Á với 10 nền tảng mang ngôn ngữ địa phương.
Hello Bacsi không chỉ là nền tảng cung cấp các thông tin y tế uy tín mà còn là đơn vị cung cấp các giải pháp Digital Marketing cho các doanh nghiệp hoạt động trong lĩnh vực chăm sóc sức khoẻ. Bằng nền tảng hiện có cùng với các giải pháp chất lượng cho mạng lưới khách hàng của mình, Hello Bacsi đang dần khẳng định vị thế là đơn vị tiên phong về giải pháp truyền thông, quảng cáo cho các doanh nghiệp ngành chăm sóc sức khoẻ trong thời đại công nghệ số.
Accelerating Patient Care with Real World EvidenceCitiusTech
Life sciences and pharma companies are evolving their strategies to utilize Real World Data (RWD) to demonstrate value of pharmaceutical and medical device innovations. Technology advancements at the point of care and improvements in data collection strategies have led to a significant increase in the availability of RWD in healthcare
Real World Evidence (RWE) can provide actionable patient insights and accelerates time to market of new medical products in order to gain competitive advantage
With the emergence of wearable technologies, Internet of Things (IOT), Cognitive Computing, Genomics, Blockchain, etc., future RWE data sources will become more diverse and extensive. This document introduces the concept of Real World Evidence studies in healthcare, describes the various data sources for performing real world analytics and illustrates the role of RWE in better patient care. It then summarizes challenges faced while performing RWE analytics with respect to regulatory compliance, data accessibility and sharing, analysis reporting, costs etc.
Digital technology advancements like Internet of Things (IoT)
* Wearable technologies
* Blockchain
* Robotics
* Big data
*Advanced analytics are changing consumer perceptions
The Future of Healthcare in Consumerism WorldCitiusTech
The main aim of this document is to provide an overview of healthcare consumerism, its growth drivers and challenges / barriers providers and payers face while adopting it. The document provides insights on how providers and payers can tackle the rising wave of consumerism in healthcare industry. The document also provides some real-life examples on market trends which emphasize the need to brace consumerism in healthcare
This document provides information about the mHealth + Telehealth World 2014 conference to be held July 22-24, 2014 in Boston, MA. The conference will focus on increasing efficiency, encouraging engagement, and ensuring sustainability of connected health programs through the combined use of mHealth and telehealth technologies. It outlines the conference agenda which includes sessions on creating sustainable business models, understanding legislation and regulations, overcoming security issues, and transitioning programs from pilots to standard practice. It invites health executives from various sectors to attend and learn strategies to successfully utilize mHealth and telehealth.
Avident Health created by doctors to allow better teamwork in healthcare and to engage and educate patients. More teamwork leads to value: Better quality at lower cost.
Similar to NCCR'16 Deloitte Presentation Karin Wellbrock 20160715 (20)
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
1. 10th National Conference for Clinical Research 2016
27 – 28 July 2016 | Hotel Istana, Kuala Lumpur, Malaysia
What about me?
Will Big Data enable patient centricity?
Presented by:
Karin Wellbrock
Senior Manager – Deloitte Consulting Pte Ltd
BIG DATA DRIVING CLINICAL RESEARCH
FOR HEALTH
2. All players in the healthcare ecosystem are zooming in
on the patient
With the healthcare ecosystem’s focus on the patient, pharma companies have to
overcome the barrier that regulators place limiting their access to patients
Understanding the patients
In depth interviews ahead of launches
and marketing – “Catalytic Contacts”
Engaging patients
Use of online and mobile solutions to
engage patients – Digital Patient Journey
Providing financial support
Providing payment process support to
patients – Guidance and Patient Support
Closing the gap between pharma companies and the
healthcare consumers
Patient
Physician
Pharmacy
Pharma Co
Insurance Co
$
?
Patient Centricity
Source: Kantar Health Unlocking Rich Patient Insights, Vertex Guidance and Patient Support Programme Information,
Deloitte Digital Patient Journey
3. • Actively seeks value
• Financially prepared
• Prefers alternative
medicine
• Cost-conscious
• Least compliant
• Heavy healthcare users
• Financially prepared
• Adheres to treatment
recommendations
• Open to electronic
communications
Patients are becoming more demanding and engaged
healthcare consumers
Shop and Save
Out and About
Casual and Cautious
Sick and Savvy
Content and Compliant
Healthcare Consumer
Segments
Trust in doctors
Use of online
resources
Use of and interest in
health technologies
Selected
Features
ModerateHigh Low
Source: Deloitte Center of Health Solutions Survey of US Health Care Consumers, 2009-2015
Size of
Segment
11%
22%
6%
34%
8%
Online and Onboard
19%
4. Deloitte study finds those health consumers most interested in
digital are also in need of care
Level of engagement
HighLow
High
Useofsystem(needforcare)
Casual and
Cautious
34%
Content and
Compliant
22%
Sick and
Savvy
11%
Online and
Onboard
19%
Out &
About
8%
Shop&
Save
6%
Consumers’ use of the health care system and
level of engagement by segment
Most digital users
43%
39%
27%
18%
14% 20%
25% 43%
19% 18%
19%
15%
5%
7% 17%
17%9%
9%
8%
6%10% 7%
2% 1%
Millennials Gen X Boomers Seniors
Segment profiles by age group
Casual and Cautious Content and Compliant Online and Onboard
Sick and Savvy Out and About Shop and Save
Source: Deloitte Center of Health Solutions Survey of US Health Care Consumers, 2009-2015
5. Big data enables better understanding of health consumers and
will ultimately led to enhanced patient treatment
Big data will be critical at all stages of the patient and product life cycles of pharma
companies and will enable patient centricity
Outcomes Demographic
Lab value
Diagnosis
Medical history
Hospital
dispensing
Prescriptions
Hospital stays
Procedures
Specialist
care
Future types of patient data
Sources: Mckinsey&Co Pharma Medical Affairs 2020 and Beyond, Tata Consultancy Services The New Frontier for the
Pharmaceutical and Life Sciences Industry: Real Big Value from Big Data, SAS Real-world evidence: Why pharma firms are
investing
Clinical Trials
Production &
distribution
Strategy
development
Launch
Lifecycle
management
Big data use in patient and product life cycles
Enables personalized medication
Use of demographics and genome
sequence data
Improves patient care quality
Through outcome feedback from multiple
sources
Uncovers underserved markets
From disease trends and drug outcomes
data
Enhances drug safety
RWE helps to unveil undesirable drug
effects early
Hospital / Specialist Care Primary Care Others
6. The Malaysian Healthcare vision should assist the players in the
health eco-system to move towards patient centricity
Patient
• Wellness
• Registration
• Health records
• Self Monitoring
• Health Apps
Clinics / Hospitals
• Health Education
• Counselling
• School Health
• Billing and Payment
• Administration
• Patient Management
Government
• EMR
• eGov Apps
• Real world evidence
• Health surveillance
Patient Centric
Data Driven
Malaysia’sHealthcareVision
7. However, the current Healthcare IT landscape in Malaysia still
needs to overcome hurdles to connect and link the players
Public
Local Taxes Government General Revenue
Local Authority Ministry of Health
Government
Health and
Wellness
Programs
Government
Healthcare
Providers
Local Health
and Wellness
Programs
Other
Ministries and
Departments
• Hospitals
• Clinics
• Doctors
EPF and
Soc.Security
Urban
Population
General
Population
Universal
Coverage
Special
Population
Groups
Private
Employers Individuals
Private Insurers, Managed
care schemes
Private Providers
• General
Practitioner
• Family
Medicine
Specialists
• Specialist Clinics
• Hospitals
• Dentists
• Pharmacies
• Pathology Providers
• Traditional &
Complimentary
Medicine
Population that can afford private insurance
System
Funding
Sources
Purchasers
Providers
Coverage
Community
Health
Individual
Health
Within the government between
public health programs and
healthcare providers
Between public and
private healthcare
providers
No interaction
8. We see pharma companies are increasingly more taking a
holistic view on patient programs …
Patient engagement examples
• Research
oriented by
patient
insights
• RWE driven
development
• Personalization
of packing to
serve patient
needs
• Direct patient
supply (for rare
diseases)
• Capture patient
insights during
trial
• RWE driven
primary
outcomes
• Patient managed
services
• Personalized
reimbursement
• Patient pathway
analysis
• Education
through remote
technologies
• Patient
reference groups
• Homecare
collaboration
• Adherence
programs
• Affordability
programs
• Social listening
• Patient
outcome &
experience
monitoring
Exploratory clinical
development
Full clinical
development
Production &
distribution
Strategy
development
Launch
Lifecycle
management
R&D
Manufacturing
Logistics
Strategy
Market Access
Sales and marketing
Post LOE
… and their design spans across all phases of their product as well as patient life cycles
Source: Deloitte Research
9. Currently, the maturity levels of patient programs vary greatly
and do not correlate with the maturity of
pharma organizations as such
Awareness of need for patient engagement
but not defined strategy and/or lacking enabling technology to realize
Defined engagement strategy and enabled basic service offerings, such as
• Patient websites with educational materials
• Start-up assistance
• Reimbursement support tools
• Access to health care providers for questions (e.g., nurse hotline)
Integrated, cloud-based platform offering more complex services, such as
• Self-tracking tools to help patients manage own care
• Click-to-chat for on-demand support
• Reminder/alert tools for treatment adherence
• Portal access for both patients and providers
Leveraging analytics from data gathered and novel offerings, such as
• Predictive interventions based on medication adherence behaviors
• Site-of-care-matching based on patient location
• Wearable therapy tracking and drug administration
1
2
3
4
Source: Deloitte Research
10. While maturing patient programs, pharma companies need to
overcome multiple internal roadblocks
People, culture and
organization within the
pharma organization
Governance and
processes pertaining to
patient data
Technology adoption and
democratization for big data
analytics
3 typical challenges impeding the realization
of patient centricity
1 2
3
11. Usual challenges related to organization culture hindering
patient centricity and use of big data are
Limited local presence in
CXO teams
Skewed incentive structure
across functions
No intra-team collaboration
within pharma org
• Regional COEs take on functions
of local organizations in South
East Asia resulting in lack of in-
depth local expertise
• SEA markets are used as
leadership training grounds for
global talent
• Mis-aligned objectives and
resulting incentive structures
for sales and medical affairs
hinder realization of patient
centricity
• Functions work in isolation on
their interpretation of patient
centricity and lack
communication, e.g. R&D,
Regulatory, Compliance,
Medical Affairs, Government
Affairs, Marketing and Sales
Patient centricity needs to embraced cross-functionally and programs tailored to meet
the local patient needs
Source: Deloitte Research
12. Lack of data governance and poor internal and external
linkages hinder effective use of big data
Decision Decision Decision Decision
Product Mger
Sales Mger
MSL Engineer External Partners
Source: Deloitte Research
The ‘asset’ data needs to be strictly governed yet made available to all stakeholders
R&D
Marketing
& Sales
Medical
Affairs
Engineering
Manufacturing
External
Researcher
13. Technology barriers impede optimal use of analytics
to drive patient centricity
Analytics organization
in pharma companies
A pure technology function –
disjoint from business needs
with no clear mandate
Business lacks
empowerment to
employ analytics for their
own insight generation
Technology decision not
accounting for business
needs
Missing data ownership
and data aggregation
A ‘single source of trust’ of patient data must be established and managed
Source: Deloitte Research
14. Connecting with patients to provide
access to and support with
treatment and care options
A holistic approach and common understanding within the
organization allow effective use of big data
Making treatments affordable
and providing resources to stay
on therapy
Active engagement with patients
during trials and assisting with
transitioning from clinical to
commercial drugs
Granting patients access to
programs via traditional and
emerging channels to support
their unique treatment journeys
and enable better long-term
treatment outcomes
Delivering educational insights to
patients for better decision
making and behavior change
Underlying layer
of big data